Yes PLCSF is a buy if you don't mind tying your money up for a couple of years. There will be much dilution unless they get a partner to come in or a buy out happens. They need money to finish the
US trials and outside of a bank lending them money (which is probably not going to happen anytime soon) they will have to issue lots of shares at 5 to 10 cents a share. I think they will get the money they need to finish the trials and the trials will be succesful but it will come at a dilutive cost.It does look like they are getting some traction overseas though so this could help offset some of the dilution if the sales department keeps doing it's job. Just my 2 cents worth.